Chemicals and Materials and Packaging · Published Aug 2026
Chelating Agents Market
The global chelating agents market is projected to grow from USD 11.4 billion in 2025 to USD 18.4 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.9%. This expansion is driven by increasing demand across key end-use industries, including pulp and paper, cleaning, water treatment, agro-chemicals, and personal care. The market is segmented by type into non-biodegradable and biodegradable chelating agents, with biodegradable alternatives gaining traction due to regulatory and sustainability pressures.
Regional growth is led by Asia-Pacific, followed by North America and Europe, as industrialization and environmental regulations shape demand dynamics.
Market size
Growth trajectory through 2035
Chelating Agents Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01 Regulatory Shifts
- The EU and U.S. have tightened restrictions on traditional chelants like EDTA and NTA, accelerating the adoption of greener alternatives such as MGDA and GLDA.
-
Development 02 Product Innovations
- BASF and Dow have launched new biodegradable chelating agents targeting water treatment and cleaning applications, aligning with sustainability trends.
-
Development 03 Supply Chain Resilience
- Companies are diversifying sourcing strategies to mitigate raw material shortages, particularly for precursor chemicals used in biodegradable chelants.
-
Development 04 Partnerships and Collaborations
- Strategic alliances between chemical manufacturers and technology providers are enabling the development of advanced chelating agent formulations with improved performance and reduced environmental impact.
Emerging opportunities added
- Bio-Based Chelating Agents Growth in demand for bio-based and green chelating agents presents opportunities for innovation, particularly in cleaning, personal care, and water treatment applications.
- Emerging Markets Rapid industrialization in Asia-Pacific and Latin America is creating new demand centers for chelating agents, especially in water treatment and agro-chemicals.
- Regulatory Incentives Government policies promoting sustainable chemistry and circular economy principles are expected to accelerate the adoption of biodegradable alternatives.
- Digital Formulation Platforms Advances in digital tools for chemical formulation are enabling more efficient development and testing of new chelating agent formulations, reducing time-to-market.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $11.40 Bn
- CAGR
- 4.90%
- Expansion
- 1.6×
Market shape
top segment · 59.5% share
- Leading region
- Asia Pacific
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- Regulatory Hurdles
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Regulatory Shifts: The EU and U.S. have tightened restrictions on traditional chelants like EDTA and NTA, accelerating the adoption of greener alternatives such as MGDA and GLDA
+3 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 80-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Chelating Agents Market today ($11.40 Bn base), and how fast will it grow at 4.9% CAGR through 2035?
- How is demand distributed across sustainability pressures, cost efficiency are prioritized applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America, and MEA compare on market share and growth rate?
- Where do Evonik Industries AG, PPG Industries, Sherwin-Williams Company and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Regulatory Compliance) and top restraints (led by Regulatory Hurdles), with quantified CAGR impact?
- What regulatory shifts and 4 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Regulatory Compliance Stringent environmental regulations, particularly in the EU and North America, are accelerating the shift from traditional aminopolycarboxylates (e.g., EDTA, NTA) to greener alternatives such as ethylenediamine disuccinic acid (EDDS), methylglycinediacetic acid (MGDA), and glutamic diacetic acid (L-GLDA).
- Industrial Demand Growth Expansion in end-use sectors including water treatment, pulp and paper, and agro-chemicals is driving sustained demand for chelating agents to enhance process efficiency and product performance.
- Sustainability Trends Increasing consumer and corporate focus on sustainability is boosting adoption of biodegradable chelating agents, which offer reduced environmental impact compared to conventional options.
- Technological Advancements Innovations in chelant formulations are improving efficacy and reducing toxicity, further supporting market growth.
Restraints
Holding it back
- Regulatory Hurdles Approval timelines for new chelating agents have extended by 6–12 months post-2025, particularly in regions with stringent chemical safety frameworks.
- Supply Chain Constraints Component and raw material shortages, notably for precursor chemicals used in biodegradable chelants, persisted through H1 2025, impacting production timelines.
- Toxicity Concerns Persistent concerns over the environmental and health impacts of traditional chelants (e.g., EDTA, NTA) continue to limit their use, despite their established performance advantages.
- High Costs of Alternatives Biodegradable chelating agents often carry higher production costs, which can deter adoption in price-sensitive applications.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Regulatory Compliance | +2.2% | Global | 2025–2035 |
| Industrial Demand Growth | +1.4% | Global | 2025–2035 |
| Sustainability Trends | +1.1% | Global | 2025–2035 |
| Technological Advancements | +0.7% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Regulatory Hurdles | −0.9% | Global | 2025–2029 |
| Supply Chain Constraints | −0.6% | Global | 2025–2029 |
| Toxicity Concerns | −0.4% | Global | 2025–2029 |
The chelating agents market is segmented by type and application:
Revenue share by type · 2025 base year
% OF $11.40 BN CHELATING AGENTS MARKET · 2 TYPES COVERED
Each slice = that type's share of the total $11.40 Bn Chelating Agents Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By application
-
sustainability pressures
-
cost efficiency are prioritized
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $11.40 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
Asia Pacific leads regional demand at ~50.9% in 2025. Driven by manufacturing scale and end-market density.
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The chelating agents market is moderately consolidated, with leading players such as BASF, Dow, DuPont, SABIC, LyondellBasell, ExxonMobil Chemical, Shell Chemicals, INEOS, and Air Liquide. These companies compete on product innovation, sustainability credentials, and regional distribution networks. Smaller players and regional manufacturers are focusing on niche applications and bio-based alternatives to differentiate their offerings. Mergers, acquisitions, and partnerships are common strategies to expand product portfolios and geographic reach.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Evonik Industries AG
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
PPG Industries
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Sherwin-Williams Company
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
AkzoNobel N.V
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Nippon Paint Holdings
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Axalta Coating Systems
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
RPM International
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
H.B. Fuller Company
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
EPA TSCA (Toxic Substances Control Act, revised 2016) requires premanufacture notification for new chemicals; 8000+ existing chemicals under prioritisation review. OSHA HazCom aligned with GHS. Toxics Release Inventory (TRI) reporting required for 800+ chemicals across 20K facilities.
-
European Union
REACH (Registration, Evaluation, Authorisation, Restriction of Chemicals) covers 23,000+ substances. CLP Regulation aligns EU with GHS. Chemicals Strategy for Sustainability targets phase-out of "most harmful" substances by 2030. PFAS restriction proposal covers 10,000+ compounds.
-
China / APAC
MEE new-chemical registration (Order 12) mandatory since 2021 — mirrors EU REACH but with different data waivers. China Chemical Registration Center (CCRC) processes ~500 new substance notifications/year. Japan's CSCL and Korea's K-REACH add region-specific requirements.
-
Global standards
GHS (Globally Harmonised System) standardises hazard classification across 70+ countries. Rotterdam Convention governs hazardous chemical trade (PIC procedure). Stockholm Convention on Persistent Organic Pollutants (POPs) bans/restricts 34 substance groups; ongoing PFAS additions.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
How big is the Chelating Agents Market in 2025?
The Chelating Agents Market is estimated at approximately $11.40 Bn in 2025, based on triangulated bottom-up revenue and top-down macro modelling. Full annual data in the report data pack.
-
What's the forecast growth rate through 2035?
The market is projected to grow at a 4.90% CAGR from 2025 to 2035, reaching $18.39 Bn by 2035. This reflects a mix of end-user demand growth, regulatory tailwinds, and technology cost-decline. Sensitivity tables in the sample.
-
Which region leads the market?
Asia Pacific leads the market, accounting for approximately 50.9% of 2025 revenue. Country-level detail is broken out in the report.
-
Which segment leads the market?
Non- Biodegradable leads the type segmentation with an estimated 59.5% share. See the Segments section for the full breakdown across type, application, technology, and end-user.
-
Who are the major players covered?
The report profiles 15 named players including Evonik Industries AG, PPG Industries, Sherwin-Williams Company, AkzoNobel N.V, Nippon Paint Holdings, and others. Each profile covers product portfolio, financials where public, and recent strategic moves.
-
What's driving growth in this market?
The top growth driver is Regulatory Compliance. Stringent environmental regulations, particularly in the EU and North America, are accelerating the shift from traditional aminopolycarboxylates (e.g., EDTA, NTA) to greener alternatives such as ethylenediamine disuccinic acid (EDDS), methylglycinediacetic acid (MGDA), and glutamic diacetic acid (L-GLDA).
-
What are the main restraints?
The primary restraint is Regulatory Hurdles. Approval timelines for new chelating agents have extended by 6–12 months post-2025, particularly in regions with stringent chemical safety frameworks.
-
What are the most recent developments?
Recent notable events include: : Regulatory Shifts: The EU and U.S. have tightened restrictions on traditional chelants like EDTA and NTA, accelerating the adoption of greener alternatives such as MGDA and GLDA; : Product Innovations: BASF and Dow have launched new biodegradable chelating agents targeting water treatment and cleaning applications, aligning with sustainability trends; : Supply Chain Resilience: Companies are diversifying sourcing strategies to mitigate raw material shortages, particularly for precursor chemicals used in biodegradable chelants. Full timeline in the report.
-
Can I customise the scope?
Yes. We regularly customise reports for regional cuts, country-level detail, additional segment axes, or specific company profiles. Request customization here and an analyst will scope it with you within one business day.
The Chelating Agents Market is projected to reach $18.39 Bn by 2035, up from $11.40 Bn in 2025 — a 4.90% CAGR equating to roughly 1.6× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.